• Explore /
  • Poster
  • / Real world prospective evaluation of clinical outcomes in patients with non-metastatic castrate resistant prostate cancer treated with darolutamide.

Real world prospective evaluation of clinical outcomes in patients with non-metastatic castrate resistant prostate cancer treated with darolutamide.

Abstract Poster

Authors

null

Amarnath Challapalli

Bristol Haematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Amarnath Challapalli , Emily Renninson , Paul White , Thiraviyam Elumalai , Omi Parikh , Alexander Vickers , Alison Jane Birtle , Andrew Brocklehurst , Rajanee Bhana , Kanchana Wickramasinghe , Kamalram Thippu Jayaprakash , Emma Gray , Matthew Sephton , Anna Bowzyk Al-Naeeb , Emily Foulstone , Alexandra Soundy , Lauren Ashurst , Amit Bahl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 335)

DOI

10.1200/JCO.2023.41.6_suppl.335

Abstract #

335

Poster Bd #

L13

Abstract Disclosures

Similar Posters

First Author: Andrew Leonard Laccetti

First Author: Efthymios Papadopoulos

First Author: Richard Gagnon

First Author: Geraldine Martineau